5,361 Shares in The Clorox Company (NYSE:CLX) Acquired by IRON Financial LLC

IRON Financial LLC bought a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 5,361 shares of the company's stock, valued at approximately $873,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Innealta Capital LLC acquired a new stake in shares of Clorox in the second quarter worth approximately $30,000. Trifecta Capital Advisors LLC increased its stake in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock worth $30,000 after buying an additional 130 shares during the last quarter. First Foundation Advisors bought a new stake in shares of Clorox in the first quarter worth $31,000. Family Firm Inc. bought a new stake in shares of Clorox in the second quarter worth $31,000. Finally, Quarry LP increased its stake in Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company's stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Up 1.2 %

Shares of CLX traded up $1.94 during trading hours on Thursday, reaching $158.45. The company's stock had a trading volume of 3,622,671 shares, compared to its average volume of 1,238,297. The firm has a market cap of $19.68 billion, a price-to-earnings ratio of 82.10, a P/E/G ratio of 3.19 and a beta of 0.41. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.09. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The company has a 50 day moving average of $161.14 and a two-hundred day moving average of $145.90.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the company earned $0.49 EPS. The firm's quarterly revenue was up 27.0% on a year-over-year basis. As a group, research analysts predict that The Clorox Company will post 6.64 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be issued a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.08%. Clorox's dividend payout ratio is currently 252.85%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CLX. BNP Paribas raised shares of Clorox to a "strong sell" rating in a report on Friday, September 6th. Citigroup upped their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a report on Friday, September 6th. DA Davidson reissued a "neutral" rating and issued a $153.00 price target on shares of Clorox in a report on Friday, September 6th. Barclays upped their price target on shares of Clorox from $130.00 to $137.00 and gave the company an "underweight" rating in a report on Friday, October 11th. Finally, TD Cowen assumed coverage on shares of Clorox in a report on Tuesday, July 23rd. They issued a "sell" rating and a $122.00 price target for the company. Six analysts have rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $150.14.

Insiders Place Their Bets

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company's stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company's stock, valued at $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.51% of the company's stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.